Alexander J. Szubert
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV.
Journal: Antimicrobial agents and chemotherapy
Published: September 26, 2025
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIV.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 16, 2025
Longitudinal changes in bone mineral density among children living with HIV over 96 weeks following switch to second-line antiretroviral therapy in Uganda.
Journal: PLOS global public health
Published: May 23, 2025
Second-Line Antiretroviral Therapy for Children Living with HIV in Africa.
Journal: The New England journal of medicine
Published: May 14, 2025
Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children with HIV in the CHAPAS-4 trial.
Journal: AIDS (London, England)
Published: April 18, 2025
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV.
Journal: The Journal of antimicrobial chemotherapy
Published: June 03, 2024
Clinical Subphenotypes of Staphylococcus aureus Bacteremia.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 04, 2024
Comparison between dual energy X-ray absorptiometry and calcaneal quantitative ultrasound for determining bone mineral density in children living with HIV in uganda: A cross- sectional study.
Journal: BMC pediatrics
Published: December 07, 2023
When should factorial designs be used for late-phase randomised controlled trials?
Journal: Clinical trials (London, England)
Published: October 31, 2023
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 15, 2023
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 17, 2023
Last Updated: 09/26/2026